Tinzaparin, an alternative to subcutaneous unfractionated heparin, in patients with severe and end-stage renal impairment: a retrospective observational single-center study
Journal of Thrombosis and Haemostasis · 2024
DOI: 10.1016/j.jtha.2024.07.006 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2024. Verfasst von Isabelle Gouin-Thibault und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Hematology, Pontchaillou University Hospital of Rennes, Rennes, France; Institut de Recherche en Santé, Environnement et Tra…. Hauptthemen laut MEDLINE: Tinzaparin, Glomerular Filtration Rate, Hemorrhage, Heparin. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Tinzaparin could be easier to manage than unfractionated heparin in patients with severe renal impairment. However, clinical and pharmacologic data regarding its use in such patients are lacking. OBJECTIVES: The aims of this study were to determine, in patients with estimated glomerular filtration rate (eGFR) of
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Hematology, Pontchaillou University Hospital of Rennes, Rennes, France; Institut de Recherche en Santé, Environnement et Travail (IRSET)-Institut National de la Santé et de la Recherche Médicale…
- Institut de Recherche en Santé, Environnement et Travail (IRSET)-Institut National de la Santé et de la Recherche Médicale (INSERM)-1085, University of Rennes, Rennes, France; Department of Anesthesia and Critical Care,…
- Department of Pharmacy, Pontchaillou University Hospital of Rennes, Rennes, France.
- Institut National de la Santé et de la Recherche Médicale (INSERM), Laboratoire Traitement du Signal et de l'Image (LTSI) -1099, University of Rennes, Pontchaillou University Hospital of Rennes, Rennes, France.
- Department of Internal Medicine and Clinical Immunology, Rennes University Hospital, Rennes, France.
- Department of Laboratory Hematology, Pontchaillou University Hospital of Rennes, Rennes, France.
Zitieren
APA
Gouin-Thibault, I., Mansour, A., Caribotti, C., Pierre-Jean, M., Bouzille, G., Ballerie, A., Maucorps, L., Gueret, P., Nédelec-Gac, F., Pontis, A., Mahé, G., Vannier, S., Behar, N., Cardiet, I., Mismetti, P., Frouget, T., & Delavenne, X. (2024). Tinzaparin, an alternative to subcutaneous unfractionated heparin, in patients with severe and end-stage renal impairment: a retrospective observational single-center study. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2024.07.006
Vancouver
Gouin-Thibault I, Mansour A, Caribotti C, Pierre-Jean M, Bouzille G, Ballerie A, et al. Tinzaparin, an alternative to subcutaneous unfractionated heparin, in patients with severe and end-stage renal impairment: a retrospective observational single-center study. Journal of Thrombosis and Haemostasis. 2024. doi:10.1016/j.jtha.2024.07.006
BibTeX
@article{GouinThibault2024,
author = {Gouin-Thibault, Isabelle and Mansour, Alexandre and Caribotti, Charlène and Pierre-Jean, Morgane and Bouzille, Guillaume and Ballerie, Alice and Maucorps, Laure and Gueret, Pierre and Nédelec-Gac, Fabienne and Pontis, Adeline and Mahé, Guillaume and Vannier, Stéphane and Behar, Nathalie and Cardiet, Isabelle and Mismetti, Patrick and Frouget, Thierry and Delavenne, Xavier},
title = {Tinzaparin, an alternative to subcutaneous unfractionated heparin, in patients with severe and end-stage renal impairment: a retrospective observational single-center study},
journal = {Journal of Thrombosis and Haemostasis},
year = {2024},
doi = {10.1016/j.jtha.2024.07.006}
}
EUVIMED